|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaabout 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketabout 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themabout 9 years ago
Reducing the Risk of Noncomplianceabout 9 years ago
When You Need Experts, Use Themabout 9 years ago
Pricing Pressures and Policy Changesabout 9 years ago
Not Your Typical Pharma Datelineabout 9 years ago
Market Access: Current and Future Statesabout 9 years ago
Market Access: A UK Perspectiveabout 9 years ago
Country Report: SingaporeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5